Skip to content
Company Analysis

Avita Medical, Inc. RCEL

A comprehensive view of key metrics, scores, and financial health for Avita Medical, Inc.

Overview of AVITA Medical, Inc.

RCEL NCM
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Small Cap
AVITA Medical, Inc. (RCEL), is a Small Cap company, in the Medical Devices industry, last closed at $15.18, about 92.1% overvalued vs fair value, +314.8% 1Y return, ranked 769/1145 in sector.
Metrics Rev Growth 11.5% ROE 799.7% Gross Margin 82.1%
USD 15.18
-2.13%
(Delayed)
• Vol 90d: 110.4%
52-Week Range
Market Cap
$469.47M
Enterprise Value
$506.99M
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Fair
Health
Weak
Efficiency
Fair
Valuation
Weak
Growth
Fair
Profitability
Fair
Health
Weak
Efficiency
Fair
Valuation
Weak
Completeness: 82%
Confidence: 86%
Updated: Oct 24
Top Beats

Quick Facts

Website https://avitamedical.com
HQ Valencia, CA
Employees 226
Fiscal year Dec 31

Next Events

Earnings Nov 5 Call: Nov 5

Fair Value Snapshot

Bear Base Bull
$1
$1
$2
Current: $15.18 -92% vs base

Engine Room Money Flow™

Small Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$71.6M
11.5%%
Gross Profit
$58.8M
6.6%%
Operating Income (GAAP)
-$42.5M
24.8%%
EBITDA
-$41.2M
25.5%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
82.1%
Excellent

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
1/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Avita Medical, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
50
/100
Moderate
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Elite Gross Margins Gross margin quality is top-tier vs peers (score 0.88). This signals strong consumable attach-rate economics.
  • Improving FCF Trend FCF trend score is positive (score 0.71). Improving FCF margin signals compounding operational leverage.

Key risks

  • Weak Capital Return Profile Capital return quality is below peers (score 0.17). Low ROIC raises questions about M&A discipline and pipeline ROI.
  • Declining Capital Returns ROIC durability is weak (score 0.35). Volatility or decline in returns is a leading moat erosion signal.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Strong
76
Premium

Signals, strengths and risks for Pricing Power & Consumable Moat

Premium

Signals, strengths and risks for R&D Pipeline & Capital Returns

Premium

Signals, strengths and risks for FCF Quality & Cash Conversion

Premium

Signals, strengths and risks for Commercial Execution

Premium

Signals, strengths and risks for Capital Structure & Resilience

Premium

Signals, strengths and risks for Growth Durability

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 76% Coverage
Trade-Off Triangle Visualization A ternary plot showing RCEL's balance between Growth (48.8%), Profitability (33.8%), and Safety (17.4%). Growth 49% Safety 17% Profitability 34%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

60th percentile vs peers
61
Key Signals
Rev Growth YoY 11.5% 60p Revenue CAGR 3Y 27.7% 81p EPS Growth YoY 27.0% 52p Asset Growth YoY -29.2% 8p
Strengths
  • Revenue CAGR 3Y in top 20% of peers (27.7%, 81th percentile)
  • Gross Profit Margin in top 20% of peers (82.1%, 90th percentile)
  • Growth above peer median with strong metric coverage (75%)
Risks

No significant risks identified for this axis.

Profitability

42th percentile vs peers
42
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

21th percentile vs peers
22
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Avita Medical, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$1.20
- - -
-92.1% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000